These trials aim to assess not only the reduction in binge eating episodes but also the long-term effects on weight management and overall mental health
WEGOVY PILL RECEIVES FDA APPROVAL December 2025 On December 22, 2025, Novo Nordisk announced that its oral semaglutide pill, to be named Wegovy, like the injection, was FDA-approved for weight loss
In my clinical experience, hair shedding tracks with the rate and amount of weight loss, not the specific drug
A hypothetical 60 mg dose could overstimulate these pathways rather than enhance therapeutic effects
Pure Encapsulations also takes transparency a bit further: While it lists its proprietary glutathione complex BioGlute on the ingredient label, it breaks down exactly what is in it250 mg of Setria l-glutathione and 125 mg of a phospholipid complexfor total clarity
And yet, what may the biggest breakthrough in addiction medicine in the past 50 years is stuck in limbo, without a path to broad access for patients